MMP2 and central nervous system cancer: Findings of the present study demonstrate the anti-tumor efficacy of combining a plasmid vector-mediated MMP-2 inhibitor (p-MMP-2) with ionizing radiation to target radiation-induced invasiveness and angiogenesis in glioma cells.